{"member_organisations": "http://www.eaepc.org/about-us/membership/list-of-members", "identification_number": "509882515669-01", "fields_of_interest": "Competition, Enlargement, Business and Industry, Single market, Public Health", "head_office_address": "Rue du Commerce 123", "full_time_equivalent_fte": "2,25", "person_with_legal_responsibility": "Richard Freudenberg", "industry_forums": "", "grants": "", "country_code": "be", "inter_groups": "", "eu_initiatives": "Issues related to the implementation of  the Directive 2011/62/EU known as the Falsified Medicines Directive \n \nAccess to medicines", "level_of_interest": "European", "organisation_name": "European Association of Euro-Pharmaceutical Companies (EAEPC)", "belgium_office_post_code": "", "number_of_persons_involved": "3", "person_in_charge_of_eu_relations": "Kasper ERNEST", "section": "II - In-house lobbyists and trade/business/professional associations", "lon": "4.37065196241582", "source": "", "subsection": "Trade and business associations", "belgium_office_phone": "", "overall_budget_turnover_as_a_range": "", "belgium_office_address": "", "persons_accredited_for_access_to_european_parliament_premises": "", "registration_date": "20/01/2015", "estimate_of_costs_absolute_amount": "", "website_address": "http://www.eaepc.org", "commission_expert_groups_and_other_similar_entities_european_commission": "NA", "head_office_post_box": "", "head_office_city": "Brussels", "membership": "EAEPC is a member of the Federation of European and International Associations (FAIB)", "head_office_post_code": "1000", "position": "Secretary-General", "financial_year_start_date": "01/01/2017", "head_office_country": "Belgium", "number_of_ep_accredited_persons": "", "relevant_communication": "", "financial_year_end_date": "01/12/2017", "lat": "50.84568275", "estimate_of_costs_as_a_range": "25000-49999", "overall_budget_turnover_absolute_amount": "0", "legal_status": "AISBL", "procurement": "", "customers": "", "belgium_office_post_box": "", "goals__remit": "Safeguarding the free movement principle for licensed medical products within the EU, as article 28; counteract attempts to restrict freedom of choice for consumers via trading patterns in breach of Articles 81 & 82 EC Treaty; assist the European Commission in achieving its Single Market objective and improve health standards through the provision of safe and innovative medicines at lower costs.", "belgium_office_city": "", "head_office_phone": "(+32)28955735"}